
@Article{ecn.2013.0329,
AUTHOR = {Afsaneh Morteza, Manouchehr Nakhjavani, Firuzeh Asgarani, Azam Ghaneei, Alireza Esteghamati, Hossein Mirmiranpour},
TITLE = {The lost correlation between leptin and CRP in type 2 diabetes},
JOURNAL = {European Cytokine Network},
VOLUME = {24},
YEAR = {2013},
NUMBER = {1},
PAGES = {53--59},
URL = {http://www.techscience.com/ECN/v24n1/65682},
ISSN = {1952-4005},
ABSTRACT = {C reactive protein (CRP) is an inﬂammatory marker believed to be of value in the early prediction
of type 2 diabetes (T2DM). Recent studies have shown a positive correlation between leptin and CRP levels. Here,
we aimed to study the correlation between leptin and CRP in patients with T2DM. We also studied the effect
of metformin therapy on the CRP-leptin correlation in patients with newly diagnosed diabetes. We performed a
follow-up study on three groups of participants deﬁned as 1: patients with newly diagnosed T2DM, 2: patients
with long-standing T2DM, and 3: healthy controls. Patients with newly diagnosed diabetes were followed for three
months after the initiation of metformin therapy. The homeostatic model assessment of insulin resistance (HOMAIR)
decreased, while leptin levels (15.9 ± 1.6 versus 21.4 ± 2.5, p<0.01) increased after metformin therapy. Leptin
levels correlated signiﬁcantly with CRP in healthy controls (r = 0.48; p<0.01); patients with newly diagnosed diabetes
before (r = 0.35; p<0.05), and after (r = 0.55, p<0.001) metformin therapy, while there was no signiﬁcant correlation
between leptin and CRP in patients with long-standing diabetes (r = 0.15; p = 0.55). After multiple adjustments for
potential confounders, leptin was the best predictor of CRP in controls (β coefﬁcient = 0.433, p<0.01), and patients
with newly diagnosed T2DM who received metformin (β coefﬁcient = 0.584, p<0.01). Statin treatment did not have
any signiﬁcant effect on the results. This is the ﬁrst report demonstrating the restorative role of metformin on the
leptin-CRP correlation in patients with newly diagnosed diabetes.},
DOI = {10.1684/ecn.2013.0329}
}



